[Selection of an anti-anginous drug for the treatment of angina pectoris (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D002997:Clomipramine / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D010480:Perhexiline / Q000009:adverse effects / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D005996:Nitroglycerin; D010480:Perhexiline; D000638:Amiodarone; D002997:Clomipramine
Le choix d'un anti-angineux dans le traitement de l'angine de poitrine